On the evening of October 30, meinian onehealth healthcare holdings (002044.SZ), known as the "first stock of physical examination", released the third quarter report for 2024, showing that the company achieved revenue of 2.935 billion yuan in the third quarter, a year-on-year increase of 3.63%; and achieved a net profit attributable to shareholders of the listed company of 0.24 billion yuan, a year-on-year increase of 10.33%. Both revenue and net profit have increased, and the strong performance has returned during the peak season, presenting an impressive performance!

Journalists learned that, benefiting from the continuous high-speed growth of active health and consumer medical sectors, coupled with the aging population, the demand for personal health management consumption is strong. The specialized screening, personal physical examination, and post-examination health management services products are experiencing high-speed and high-quality growth. According to the disclosed data, the share of individual physical examination business of meinian onehealth healthcare holdings in the first half of this year exceeded 30%, a 10% increase from the same period last year. The company continues to expand high-quality customer base, while maintaining stable increase in unit price, and the demand for health consumption remains strong.

"Based on strengthening group orders and continuously optimizing customer structure, the company has been increasing its efforts in the individual physical examination business, continuously launching AI specialized and new physical examination projects and health management services to meet users' diverse and personalized health needs," stated meinian onehealth healthcare holdings. The company continues to advance its digital marketing strategy, empowering refined operations with "AI + Medical" approach to further improve efficiency, reduce costs, continuously enhance satisfaction and repurchase rate, increase unit price and brand momentum, and further drive sustainable growth and high-quality development of the company.

In a recent research report by China Securities Co.,Ltd., it was mentioned that personal consumption demands for package physical examinations and personalized specialized inspections continue to rise. With the promotion through e-commerce communities and the enrichment of products, the C-end of the physical examination industry is rapidly growing. Meinian onehealth healthcare holdings is aligning with the industry development trend by enhancing innovation in physical examination product development to increase differential competitiveness, continuously optimizing customer structure, boosting the penetration rate of high-quality B-end customers, enhancing unit price increase, and transitioning from group physical examinations to individual checks through multi-channel distribution to drive rapid growth in the C-end. In the long run, the barrier to entry in the physical examination industry is expected to increase, and industry concentration is expected to accelerate. In the current environment, meinian onehealth healthcare holdings has significantly higher safety margins due to its scale and differential advantages, which are expected to increase market share. The company's performance during the second half of the year is promising.

Empowered by AI specialized and new products, delving deep into the rich vein of personal health consumption

"The company's physical examination orders remained stable and good in the first half of the year, with business affected by the inspection rhythm gradually picking up in the third quarter," stated meinian onehealth healthcare holdings. The company is now in the peak season for physical examinations in the second half of the year, maintaining a good development momentum. "Overall, the speed of reporting for the second half of the year is better than that of the first half," while the demand for personal health consumption is strong. Focusing on professional physical examinations, the company is exploring customer demands in depth, continuously introducing high-quality AI specialized and new products to better meet the increasingly diverse and personalized health needs of users, expanding the blue ocean of personal healthcare.

It has been noticed that after years of deep cultivation in preventive medicine, meinian onehealth healthcare holdings has accumulated over one billion times of medical imaging data and 0.2 billion times of structured health data, forming the largest scale of personal health examination data center in China. Based on this data "gold mine," meinian onehealth healthcare holdings has been actively deploying AI technology in preventive applications for the past seven years, continuously launching innovative AI specialized and new products, actively laying out fields such as stroke AI diagnosis, cognitive AI diagnosis, coronary artery calcium score AI diagnosis, lung nodule AI diagnosis, electrocardiogram AI diagnosis, breast ultrasound AI diagnosis, ultrasound AI quality control, fundus AI diagnosis, and pediatric bone age AI assessment, focusing on differentiated advantage products, expanding the boundaries of health management. At the same time, the data asset entry work of meinian onehealth healthcare holdings has made initial progress, achieving the entry of financial statement data resources.

Since the beginning of the year, on the basis of launching a series of innovative products such as BrainRuijia, LungJingning, Meinian Mental Health, Genetic Testing, meinian onehealth healthcare holdings has officially launched the first domestic health management AI robot "Health Little Meixue" smart blood sugar management specialist, focusing on the full cycle management of blood sugar, innovative products such as AI traditional Chinese medicine intelligent physical examination, and many other AI specialized and new products, laying out specialized disease management new tracks, empowering precise prevention and post-examination health management, and creating new growth engines.

According to reporters, in 2023, Meinian Onehealth Healthcare Holdings achieved approximately 9% of revenue through innovative products. In the first three quarters of this year, products such as Pulmonary Ning, Brain Ruijia, Coronary Calcification Score, AMD Multidisciplinary Expert Intelligent Health System, and Digital Cloud Film have all achieved sustainable high-speed growth, fully demonstrating Meinian's innovation capability and market competitiveness in the field of artificial intelligence. As of now, Pulmonary Ning has served more than 0.1 million people, covering over 130 cities; Brain Ruijia has screened more than 0.2 million people, covering over 220 cities, with a detection rate of 14% for medium to high-risk abnormalities. In addition, the usage of Calcification Score and Cardiovascular Screening Services has exceeded 5.5 million, covering over 300 cities, with a positive detection rate of 16.5%.

Innovative products also help Meinian Onehealth Healthcare Holdings win new high-quality orders. "At the beginning of the year, we signed a big client in Chengdu. They have been undergoing physical examinations in Grade 3 hospitals for the past five or six years. This year, we secured the order at the original price without discount, solely because it includes Brain Ruijia, an innovative product," Meinian Onehealth Healthcare Holdings explained. The average customer unit price for this order reached 2000 yuan, with a total order amount of around 10 million yuan.

The aging dividend is being released, and the health management market continues to expand.

The "2024 China Health Management Industry Research Report" released by iResearch Consulting shows that by 2028, the overall health management market size will exceed 3000 billion yuan, with an annual compound growth rate of 12.5% from 2023 to 2028.

Recently, the State Council issued the "Opinions on Promoting High-Quality Development of Service Consumption," which, for health consumption, for the first time mentioned "nurturing and expanding new service formats such as health check-ups, consultations, and management." "Health consumption is one of the most important forms of future consumption." Peking University professor and director of the National Digital Health Center, Li Tao, stated that with the increase in residents' income, the upgrading of consumption structure, acceleration of aging and urbanization, the public's demand for high-quality medical and health services continues to strengthen. Health consumption will undoubtedly enter a phase of rapid growth and become one of the widest race tracks.

In June this year, the National Development and Reform Commission and other departments issued "Measures for Creating New Consumption Scenarios and Cultivating New Growth Points in Consumption," expanding new silver-haired consumption scenarios, using health consumption as a new growth point, promoting the development of health consumption, launching the "Health Consumption Leading Action," supporting social forces to enter the high-end medical service field. iMedia Consulting data shows that the silver-haired economy is in a phase of accelerated development. It is expected that by 2035, China's silver-haired economy will reach around 30 trillion yuan. With the expansion and improvement of the silver-haired economy, the aging market is also a very certain scene for the upgrading of health consumption. As a leader in the physical examination industry, Meinian Onehealth Healthcare Holdings will directly benefit.

With the increasing health demands, people are putting forward new requirements for health check-ups such as "personal health issues need real-time consultation," "comprehensive grasp of health data trends," and "personalized customization of health management solutions." The single physical examination service is no longer able to meet the increasingly diversified and personalized health needs. In view of this, in August of this year, Meinian Onehealth Healthcare Holdings cooperated with Huawei Cloud and Shanghai Runda Medical Technology to launch the first domestic health management AI robot, "Health Little Beauty," officially going online, upgrading from "one-time physical examination service" to "whole-process health management".

As a generative AI and big data-driven intelligent health management robot, "Health Little Beauty" establishes a holistic health record based on Meinian's physical examination files and deep analysis of health big data, creating a three-dimensional digital twin of the human, evaluating health risks and health management solutions, and providing value-added services such as a green medical channel, medical expert resources, to meet users' personalized, diversified, intelligent, and lean full-life health management needs, creating a new paradigm of digital health management in the era of big models.

Regarding the follow-up plan of 'Healthy Xiaomei', the company revealed that it will gradually open in each medical examination branch according to the plan. 'In the first batch of promotion, we hope to quickly reach a service coverage of one million person-times. The main functions covered include the one-click import of customers' personal health information, past medical records, and historical physical examination report data, in order to establish a full life cycle digital health file. Through these risk assessments, overall interventions after the examination, and health management measures are implemented to further improve the pre-examination, during examination, and after examination services.'

AI overlaying intelligent marketing, multiple measures to welcome the peak season of physical examinations.

Reporters found that under the theme of 'Meinian Singles' Day, Smart and Quality Selection,' Meinian Onehealth Healthcare Holdings carried out Singles' Day marketing activities on various public domain platforms such as Tmall, JD.com, Meituan, Douyin, Kuaishou, and the 'Meinian Premium Selection' private domain platform through multiple channels. Combining the characteristics and advantages of each platform, diversified channels are used to reach users, selecting multiple quality packages for users. In recent years, Meinian Onehealth Healthcare Holdings has continued to promote its digital marketing strategy, with efforts in both the B-end and C-end, expanding marketing through multiple channels online and offline to develop high-quality customers, continuously optimizing the customer structure, and building a complete customer operation system.

On traditional e-commerce platforms, the company continues to strengthen the refined operation of platforms such as Tmall, JD.com, PDD Holdings, Meituan, and Alipay. In addition, 'The company continues to strengthen the operation of Douyin, Kuaishou platforms, achieving volume growth and further enhancing overall business,' according to Meinian Onehealth Healthcare Holdings.

Building on the foundation of stable group advantages, strengthening private domain traffic operation and laying out a private domain ecosystem are the main directions for the individual examination end of Meinian Onehealth Healthcare Holdings. The company is intensifying its digital marketing efforts, promoting health communities and personalized marketing, strengthening customer interaction through the 'Meinian Premium Selection' platform, establishing precise personalized professional health solutions. The growth of private domain individual examination business and brand loyalty is rapidly increasing, further driving customer repeat purchases and conversions.

'In the individual examination field, the company will continue to focus on private domain traffic operation, public domain customer operation, especially customer operation based on traditional e-commerce public domain platforms, health community construction, closed-loop marketing system, and large ecological circle construction,' Meinian Onehealth Healthcare Holdings stated. The company continues to enhance the fission and precipitation of group clients, will continue to promote the private domain operational cloud platform 'Star Sea System,' completing the full cycle closed-loop operation of customers from reach, retention, conversion to repeat purchases, fission. With the support of marketing tools such as Enterprise WeChat, Star Sea System, Meinian Premium Selection, efficient and detailed management of individual examination customers is carried out, comprehensively promoting 'continuous import of traffic in Meinian's digital intelligence platform, private domain chronic disease management and health intervention solutions,' in order to create a growth driven by customer service solutions-oriented group and individual examination dual-wheel.

It is worth mentioning that Meinian Onehealth Healthcare Holdings is building a high-energy marketing team supported by AI. The company launched the AI intelligent sales assistant 'Mei Nian Xiao Xing,' assisting sales personnel in improving reception capabilities and business conversion rates, strengthening the professional skills of sales personnel and the speed of updating product information, empowering marketing, becoming a powerful driver of revenue growth for Meinian Onehealth Healthcare Holdings individual examination business. Reflected in data, during the AI sales agent operation project piloted in the Hangzhou area, sales personnel achieved a sales conversion rate of 8.02% through the Enterprise WeChat account during the one-month testing period, and the average additional purchase income reached 1492.27 yuan. Industry insiders say that with the all-round iteration and improvement of the AI voice system, it can comprehensively enhance the professionalism, timeliness, and conversion rate of physical examination consultations, boosting growth for C-end customers.

Looking ahead to the fourth quarter, Meinian Onehealth Healthcare Holdings stated that it will continue to strengthen the three-dimensional intelligent marketing system construction, comprehensively optimize the strategy of expanding high-quality government and enterprise customers, continuously optimize the customer structure, lock in high-quality customer scheduling, improve the penetration rate of high-quality customers, enhance high-quality group order share with a differentiated competition strategy. Simultaneously strengthening the 'group examination to individual examination' and private domain traffic operation, continuing to strengthen the deep empowerment and innovative application of intelligent AI technology and medical services in the field of digital intelligence, deeply tapping into the contribution of advantage-based specialized, special and new products for performance growth.

According to the research reports from china securities co.,ltd., the current A-shares market is entering a phase of "confidence revaluation bull". Under the "confidence revaluation bull", investors can focus on four types of investment opportunities: significantly undervalued Chinese assets, revaluation due to deflation improvement, value reassessment of leading enterprises, and resilient assets in a bull market.

As a leading enterprise in the domestic preventive medical field, meinian onehealth healthcare holdings clearly fits the point of "value reassessment of leading enterprises". Analysts from tianfeng securities stated that relying on the three major paths of "diversified revenue increase, cost reduction and efficiency enhancement, and increasing per capita consumption", meinian onehealth healthcare holdings continues to optimize its customer structure, increase the share of physical examinations, continuously promote the deep integration of "AI + medical", and innovate in product technology. With the release of physical examination capacity and the improvement of store efficiency in the second half of the year, the company continues to enhance customer experience and per customer spending. Key innovative special packages such as lung health, brain health, and mental health are expanding, and the revenue structure and profitability are continuously optimized.